SCHEMBL3685287

SCHEMBL3685287

CC(S)C(C)(C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11883945 0.79
SCHEMBL209810 0.75
SCHEMBL9273466 0.74 ALDH1A1 (0.45)
SCHEMBL3979627 0.74
SCHEMBL27911763 0.74
SCHEMBL23890067 0.74
SCHEMBL9223742 0.74
SCHEMBL9223745 0.74
SCHEMBL11360511 0.74
SCHEMBL28729281 0.73 ALDH1A1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334201-B1 THIOL-CONTAINING FRAGRANCE AND FLAVOR MATERIALS TAKASAGO PERFUMERY CO LTD (JP) 2016-07-27 EP claimed
CN-118006521-A Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol and producing related 1, 4-butanediol 基因组股份公司 2024-05-10 CN disclosed
CN-116096869-A Engineered enzymes and methods of making and using the same 基因组股份公司 2023-05-09 CN disclosed
US-7825134-B2 Amelioration of cataracts, macular degeneration and other ophthalmic diseases OTHERA HOLDING, INC. (US) 2010-11-02 US disclosed
US-20050131025-A1 Amelioration of cataracts, macular degeneration and other ophthalmic diseases COLBY PHARMACEUTICAL COMPANY 2005-06-16 US disclosed